NS
BIO icon

NBC Securities’s Bio-Rad Laboratories Class A BIO Stock Holding History

NBC Securities’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-16
Closed -$5K – 1346
2024
Q3 		$5K Hold
16
– – ﹤0.01% 1873
2024
Q2 		$4K Sell
16
-4
-20% -$1.16K ﹤0.01% 1879
2024
Q1 		$6K Hold
20
– – ﹤0.01% 1810
2023
Q4 		$6K Sell
20
-9
-31% -$2.82K ﹤0.01% 1824
2023
Q3 		$10K Buy
+29
New +$11.2K ﹤0.01% 1687

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

NBC Securities's BIO Position: Q4 2024 in Review

NBC Securities sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2024, closing a stake of 16 shares — an estimated $5K sold.

NBC Securities first reported a position in BIO in Q3 2023 and held it in 5 quarters. The position peaked at $10K in Q3 2023. 456 funds tracked by Wall St. Rank hold BIO as of Q4 2024.

  • NBC Securities reported no remaining Bio-Rad Laboratories Class A position as of Q4 2024 after selling out during the quarter.
  • NBC Securities sold 16 Bio-Rad Laboratories Class A shares in Q4 2024, an estimated $5K.
  • NBC Securities first reported a position in Bio-Rad Laboratories Class A in Q3 2023 and held it in 5 quarters.
  • NBC Securities's Bio-Rad Laboratories Class A position peaked at $10K in Q3 2023.
  • 456 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2024.

Based on NBC Securities's 13F filing for Q4 2024, filed 22 Jan 2025.